Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in utilization of an anonymous abortion and miscarriage hotline before and after <i>Dobbs v. Jackson Women's Health Organization</i>: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

The Opportunity of Abortion-Protective States in the Post-<i>Dobbs</i> Era: Implications for Public Health Policy and Practice.

American journal of public health·2026
Same author

Sexual function and orgasm experience pre- and post-gender-affirming hysterectomies.

The journal of sexual medicine·2026
Same author

Baseline sexual function of patients receiving gender-affirming hysterectomies.

Sexual medicine·2026
Same author

Impact of a Multifaceted Quality Improvement Initiative Aimed at Reducing Primary Cesarean Delivery Rates.

Joint Commission journal on quality and patient safety·2026
Same author

Sexual functioning after risk-reducing oophorectomy: a prospective study.

The journal of sexual medicine·2025

Related Experiment Video

Updated: Jun 5, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Emma Chew Murphy1, Tami S Rowen1

  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.

Obstetrics and Gynecology Clinics of North America
|June 3, 2026
PubMed
Summary
This summary is machine-generated.

Cervical cancer screening for transgender and nonbinary (TNB) individuals should follow cisgender women guidelines. Testosterone therapy may affect screening results, and self-collected HPV testing is a viable option for those facing barriers to pelvic exams.

Keywords:
Cervical cancer screeningHPV self-collectionHPV virusNonbinaryPap smearTransgenderTransmasculine

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Area of Science:

  • Gynecology
  • Transgender Health
  • Oncology

Background:

  • Cervical cancer screening guidelines for cisgender women are applicable to transgender and nonbinary (TNB) individuals.
  • Testosterone therapy in TNB individuals may lead to inadequate cervical cytology and benign cervical changes.
  • Distinguishing testosterone-induced cervical changes from high-grade dysplasia can be challenging.

Purpose of the Study:

  • To review current recommendations for cervical cancer screening in transgender and nonbinary populations.
  • To discuss the impact of testosterone therapy on cervical cytology and potential management strategies.
  • To highlight the utility of HPV testing in TNB individuals.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of the effects of testosterone therapy on cervical cytology.
  • Evaluation of alternative screening methods for TNB individuals.

Main Results:

  • Testosterone therapy is linked to increased odds of inadequate cervical cytology and benign cervical changes.
  • Topical estrogen may benefit patients experiencing testosterone-related atrophy.
  • Self-collected HPV testing is an acceptable screening method for TNB individuals who find pelvic exams difficult.

Conclusions:

  • Cervical cancer screening for TNB individuals should align with established guidelines for cisgender women.
  • Awareness of testosterone therapy's effects is crucial for accurate interpretation of cervical cytology.
  • Human papillomavirus (HPV) testing, particularly self-collected samples, offers a practical and acceptable screening approach for TNB populations.